Dermapharm Holding SE buy DirectorDealer
Start price
02.01.25
/
50%
€41.05
Target price
02.01.26
-
Performance (%)
-6.21%
End price
03.01.26
€38.50
Summary
This prediction ended on 03.01.26 with a price of €38.50. With a performance of -6.21%, the BUY prediction by DirectorDealer finished with a loss. DirectorDealer has a follow-up prediction for Dermapharm Holding SE where he still thinks Dermapharm Holding SE is a Buy. DirectorDealer has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dermapharm Holding SE | 0.629% | 0.629% | 18.694% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % |
Comments by DirectorDealer for this prediction
In the thread Dermapharm Holding SE diskutieren
Director's Dealing / Insider Kauf von Beier, Wilhelm (Aufsichtsrat)
- Handelstag: 30.12.2024
- Volumen: 3894961 €
- Meldende_r: Beier, Wilhelm
In the thread Trading Dermapharm Holding SE
Die von DirectorDealer gewählte maximale Laufzeit wurde überschritten